大型整合医疗系统中良性妇科疾病子宫切除术前替代治疗的使用情况
本研究为回顾性队列研究,在Kaiser Permanente北加州整合医疗系统内对2012至2014年因良性妇科疾病行子宫切除术的患者进行分层随机抽样,抽取1050例进行病历审查,其中979例符合纳入标准。结果显示,81.2%的患者在术前尝试过至少一种替代治疗,99.3%的患者接受了替代治疗咨询。年龄45至49岁女性较40岁以下女性术前使用替代治疗的可能性更低(调整比值比0.41,95%CI 0.21-0.76)。作者认为需进一步研究评估替代治疗使用与避免不必要子宫切除术的关系。
要点
- 81.2%的患者术前尝试至少一种替代治疗,其中33.8%使用一种,47.4%使用至少两种。
- 45至49岁女性较40岁以下女性术前使用替代治疗的调整比值比为0.41(95%CI 0.21-0.76)。
核心结论
- 超过80%的患者在因良性妇科疾病行子宫切除术前接受了替代治疗。
- 作者认为需进一步研究评估替代治疗使用与预防不必要子宫切除术的关系。
研究设计与样本
- 回顾性队列研究,加拿大任务force分类II-2。
- 研究地点为Kaiser Permanente北加州社区整合医疗系统。
- 2012至2014年因良性妇科疾病行子宫切除术的6892例患者中,按子宫切除指征比例分层随机抽取1050例进行病历审查。
- 979例(93.2%)符合纳入标准。
主要发现
- 子宫切除主要指征为症状性肌瘤(54.4%),其次为异常子宫出血(29.0%)、子宫内膜异位症(5.8%)、盆腔痛(3.1%)、痛经(3.4%)和其他(4.3%)。
- 子宫切除主要路径为腹腔镜(68.7%)和阴道子宫切除(13.4%)。
- 术前81.2%的患者尝试至少一种替代治疗,其中33.8%使用一种治疗,47.4%使用至少两种治疗;99.3%的患者接受了替代治疗咨询。
- 与年龄小于40岁的女性相比,45至49岁女性术前使用替代治疗的调整比值比为0.41(95%CI 0.21-0.76)。
- 替代治疗使用率在社会经济状态或主要种族和族裔群体之间无差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: To investigate rates of utilization of alternative treatments before hysterectomy for benign gynecologic indications within a large integrated health care system. DESIGN: Retrospective cohort study of patients who underwent hysterectomies for benign gynecologic conditions between 2012 and 2014 (Canadian Task Force classification II-2). SETTING: Kaiser Permanente Northern California, a community-based integrated health system. PATIENTS: Women who underwent hysterectomy for a benign gynecologic condition between 2012 and 2014. INTERVENTIONS: From an eligible cohort of 6892 patients who underwent hysterectomy, a stratified random sample of 1050 patients were selected for chart review. Stratification was based on the proportion of indications for hysterectomy. MEASUREMENTS AND MAIN RESULTS: The primary outcome was the use of alternative treatments before hysterectomy. Alternative treatments included oral hormone treatment, leuprolide, medroxyprogesterone intramuscular injections, a levonorgestrel intrauterine device, hormonal subdermal implants, endometrial ablation, uterine artery embolization, hysteroscopy, and myomectomy. Of the 1050 charts reviewed, 979 (93.2%) met the criteria for inclusion in this study. The predominant indication for hysterectomy was symptomatic myomas (54.4%), followed by abnormal uterine bleeding (29.0%), endometriosis (5.8%), pelvic pain (3.1%), dysmenorrhea (3.4%), and other (4.3%). The major routes of hysterectomy were laparoscopy (68.7%) and vaginal hysterectomy (13.4%). Before hysterectomy, 81.2% of patients tried at least 1 type of alternative treatment (33.8% with 1 treatment and 47.4% with at least 2 treatments), and 99.3% of patients were counseled regarding alternative treatments. Compared with younger women age <40 years, women age 45 to 49 years were less likely to use alternative treatments before hysterectomy (adjusted odds ratio, 0.41; 95% confidence interval, 0.21-0.76). There were no variations in treatment rates by socioeconomic status or between major racial and ethnic groups. The final pathological analysis identified myomas as the most common pathology (n = 637; 65.1%); 96 patients (9.8%) had normal uterine pathology. CONCLUSION: More than 80% of patients received alternative treatments before undergoing hysterectomy for a benign gynecologic condition. Additional investigation is warranted to assess alternative treatment use as it relates to preventing unnecessary hysterectomies.
引用
- Nguyen NT, Merchant M, Ritterman Weintraub ML, et al. Alternative Treatment Utilization Before Hysterectomy for Benign Gynecologic Conditions at a Large Integrated Health System. J Minim Invasive Gynecol. 2018. PMID: 30165183. doi:10.1016/j.jmig.2018.08.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。